Bank of Montreal
HRTX icon

Bank of Montreal’s Heron Therapeutics HRTX Stock Holding History

Bank of Montreal’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-500
Closed -$9K – 4232
2017
Q4 		$9K Hold
500
– – ﹤0.01% 3806
2017
Q3 		$8K Hold
500
– – ﹤0.01% 3764
2017
Q2 		$7K Buy
+500
New +$7.24K ﹤0.01% 3804
2017
Q1 		– Sell
-100
Closed -$2K – 4068
2016
Q4 		$2K Hold
100
– – ﹤0.01% 3887
2016
Q3 		$2K Buy
+100
New +$1.85K ﹤0.01% 3851

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Bank of Montreal's HRTX Position: Q4 2025 in Review

Bank of Montreal sold out of Heron Therapeutics (HRTX) in Q4 2025, closing a stake of 15,495 shares — an estimated $19.5K sold.

Bank of Montreal first reported a position in HRTX in Q4 2015 and held it in 31 quarters. The position peaked at $5.56M in Q2 2021. 170 funds tracked by Wall St. Rank hold HRTX as of Q4 2025.

  • Bank of Montreal reported no remaining Heron Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Bank of Montreal sold 15,495 Heron Therapeutics shares in Q4 2025, an estimated $19.5K.
  • Bank of Montreal first reported a position in Heron Therapeutics in Q4 2015 and held it in 31 quarters.
  • Bank of Montreal's Heron Therapeutics position peaked at $5.56M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2025.

Based on Bank of Montreal's 13F filing for Q4 2025, filed 12 Feb 2026.